High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the “SET” feature of high-grade serous carcinoma to the “STEM” feature

[1] Prat J(2018)Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics Hum Pathol 80 11-27

[2] D'Angelo E(2005)Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon Clin Cancer Res 11 6116-6126

[3] Espinosa I(2004)Grading ovarian serous carcinoma using a two-tier system Am J Surg Pathol 28 496-504

[4] Marquez RT(2009)Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems Adv Anat Pathol 16 267-282

[5] Baggerly KA(2013)The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors Mod Pathol 26 1255-1263

[6] Patterson AP(2011)Integrated genomic analyses of ovarian carcinoma Nature 474 609-615

[7] Liu J(2017)TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer Diagn Pathol 12 16-420

[8] Broaddus R(2012)Low-grade serous carcinomas of the ovary contain very few point mutations J Pathol 226 413-636

[9] Frumovitz M(2012)Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma Mod Pathol 25 625-185

[10] Malpica A(2018)High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis Diagn Pathol 13 24-992

[1] Prat J(2018)Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics Hum Pathol 80 11-27

[2] D'Angelo E(2005)Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon Clin Cancer Res 11 6116-6126

[3] Espinosa I(2004)Grading ovarian serous carcinoma using a two-tier system Am J Surg Pathol 28 496-504

[4] Marquez RT(2009)Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems Adv Anat Pathol 16 267-282

[5] Baggerly KA(2013)The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors Mod Pathol 26 1255-1263

[6] Patterson AP(2011)Integrated genomic analyses of ovarian carcinoma Nature 474 609-615

[7] Liu J(2017)TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer Diagn Pathol 12 16-420

[8] Broaddus R(2012)Low-grade serous carcinomas of the ovary contain very few point mutations J Pathol 226 413-636

[9] Frumovitz M(2012)Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma Mod Pathol 25 625-185

[10] Malpica A(2018)High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis Diagn Pathol 13 24-992